According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$121.08. In 2021 the company made an earnings per share (EPS) of -$8.47 an increase over its 2020 EPS that were of -$11.19.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$121.08 | |
2021 | -$8.47 | -24.31% |
2020 | -$11.19 | -5.41% |
2019 | -$11.83 | -72.67% |
2018 | -$43.29 | -291.46% |
2017 | $22.61 | 797.22% |
2016 | $2.52 | -34.03% |
2015 | $3.82 | -207.61% |
2014 | -$3.55 | -366.73% |
2013 | $1.33 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | -111.63% | ๐บ๐ธ USA |
General Electric GE | $8.55 | -107.06% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | -$2.00 | -98.35% | ๐ฎ๐ฑ Israel |